| Financial Year |
March 31 2023 |
| Monetary Funds |
13,097,768,040.93 |
| Held-for-trading Financial Assets |
849,682,100.18 |
| Notes Receivable |
52,506,803.33 |
| Accounts Receivable |
14,006,777,053.41 |
| Advances to Suppliers |
1,498,178,672.09 |
| Other Receivables |
618,285,829.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
21,103.18 |
| Inventories |
1,626,736,534.63 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
51,102,410.00 |
| Other Current Assets |
6,003,146,299.23 |
| Total Current Assets |
37,942,045,944.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
697,052,448.19 |
| Long-term Equity Investment |
6,742,858,299.11 |
| Investment Properties |
1,323,065,022.41 |
| Fixed Assetes |
58,647,796,627.88 |
| Under-construction Projects |
7,155,901,359.40 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
17,959,360,907.25 |
| R&D expenses |
284,519,115.34 |
| Goodwill |
2,878,877,184.01 |
| Long-Term Deferred and Prepaid Expenses |
169,480,043.58 |
| Deferred Income Tax Assets |
983,897,865.86 |
| Other Non-Current Assets |
6,255,546,861.27 |
| Sub-Total of Non-Current Assets |
110,383,676,811.04 |
| Total Assets |
148,325,722,755.34 |
| Short-Term Loans |
2,196,559,788.25 |
| Trading Financial liabilities |
-- |
| Notes Payable |
247,553,436.52 |
| Accounts Payable |
3,008,176,719.78 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,876,439,699.60 |
| Taxes Payable |
779,879,524.75 |
| Interest Payable |
-- |
| Dividend Payable |
8,810,993.01 |
| Other payables |
8,709,688,442.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,019,128,869.05 |
| Other Current Liabilities |
7,471,949,745.67 |
| Sub-Total of Current Liabilities |
33,819,200,908.55 |
| Long-term Loans |
32,152,929,679.78 |
| Bonds Payable |
14,145,350,000.00 |
| Long-Term Accounts Payable |
8,869,047,127.61 |
| Special Payable |
-- |
| Estimatied Liabilities |
601,783.45 |
| Deferred Income Tax Liabilities |
1,976,170,286.49 |
| Other Non-Current Liabilities |
671,717,570.41 |
| Sub-Total of Non-Current Liabilities |
58,896,832,189.33 |
| Total Liabilities |
92,716,033,097.88 |
| Paid-In Capital(Or Share Stock) |
4,757,389,916.00 |
| Capital Surplus |
4,502,379,257.72 |
| Surplus Reserve |
3,548,727,281.30 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
13,682,096,330.51 |
| Minority Stockholder's Interest |
8,713,879,284.65 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
46,895,810,372.81 |
| Owner's Equity（Stockholder's Equity） |
55,609,689,657.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
148,325,722,755.34 |
